Preferences help
enabled [disable] Abstract
Number of results
2000 | 47 | 1 | 87-94
Article title

Synthesis and antimicrobial activity of new adamantane derivatives I.

Title variants
Languages of publication
A series of fourteen derivatives of adamantane was synthesised. The new compound 4-(adamant-1-ylmethoxycarbonyl)phthalanhydride obtained from 1-adamantane- methanol and trimellitic anhydride chloride appeared very useful for preparation of a number of N-substituted phthalimides. Antimicrobial activity of the newly obtained derivatives such as, for example, 4-(adamant-1-ylmethoxycarbonyl)-N-(5-carboxypentamethylene)phthalimide or 4-(adamant-1-ylmethoxycarbonyl)-N-(L-alanyl)phthalimide was tested against Staphylococcus aureus, Bacillus sp., Micrococcus flavus and Enterococcus faecium. The minimal inhibitory concentration (MIC) for these compounds against S. aureus were 0.022 and 0.05 μg/ml, respectively.
Physical description
  • Agricultural University, Institute of Chemistry, Warszawa, Poland
  • Medical University, Department of Pharmaceutical Microbiology, Warszawa, Poland
  • Medical University, Department of Pharmaceutical Microbiology, Warszawa, Poland
  • Agricultural University, Institute of Chemistry, Warszawa, Poland
  • 1. Białecka-Florjańczyk, E. & Orzeszko, A. (1993) Some novel liquid crystalline derivatives of 4-carboxyphthalimide. Liq. Cryst. 15, 255- 258.
  • 2. Białecka-Florjańczyk, E., Orzeszko, A. & Śledzińska, I. (1997) Cholesteryl ester imides with oxyethylene and methylene tails. Mol. Cryst. Liq. Cryst. 300, 1-8.
  • 3. Białecka-Florjańczyk, E., Orzeszko, A., Śledzińska, I. & Górecka, E. (1999) Evidence of the smectic antiphase in 4-decyloxybiphenyl ester imide derivatives. J. Mater. Chem. 9, 371-374.
  • 4. Śledzińska, I., Białecka-Florjańczyk, E. & Orzeszko, A. (1996) Synthesis and liquid crystalline properties of cholesteryl bisester imides with poly(ethylene oxide)s as central spacer. Eur. Polym. J. 32, 1345-1350.
  • 5. Kricheldorf, H.R. (1999) Liquid-crystalline polyimides. Adv. Polym. Sci. 141, 84-188.
  • 6. Loncrini, D.F. (1966) Aromatic poly(ester imide)s. J. Polym. Sci. Part A-1. 4, 1531-1541.
  • 7. Kricheldorf, H.R. (1994) Liquid-crystalline polyimides. Mol. Cryst. Liq. Cryst. 254, 87-108.
  • 8. Kricheldorf, H.R. & Pakull, R. (1988) New polymer synthesis. 20. Liquid-crystalline poly(ester imide)s derived from trimellitic anhydride, α,ω-diaminoalkanes and 4,4'-dihydroxybiphenyl. Macromolecules 21, 551-557.
  • 9. Mallawaarachchi, W., Simmonds, R.J. & Parry, D.E. (1989) The geometry of N-hydroxymethyl compounds. Part 3: Geometries of N-(hydroxymethyl)amides related to reactivities. Anti-Cancer Drug Des. 4, 233-240.
  • 10. Davies, W.L., Grunert, R.R., Haff, R.F., McGahen, J.W., Neumayer, E.M., Paulshock, M., Watts, J.C., Wood, T.R., Hermann, E.C. & Hoffmann, C.E. (1964) Antiviral activity of 1-adamantanamine (amantidine). Science 144, 862-863.
  • 11. Schwab, R.S., England, A.C., Jr., Poskanzer, D.C. & Young, R.R. (1969). Amantadine in the treatment of Parkinson's disease. J. Am. Med. Assoc. 208, 1168-1170.
  • 12. Płachta, D. & Starościak, B. (1994) Synthesis of some 1-alkylamino-2,4-adamantylphenoxy)ethane derivatives. Acta Polon. Pharm. 51, 51-54.
  • 13. Papadaki-Valiraki, A., Papakonstantinou- Garoufalias, S., Makaros, P., Chytyroglou- Lada, A., Hosoya, M., Balzarini, J. & De Clercq, E. (1993) Synthesis, antifungal, antibacterial and antiviral effects of some adamantaneketoxime ethers. Il Farmaco 48, 1091-1102.
  • 14. Wang, J.-J., Wang, S.-S., Lee, Ch.-F., Chung, M.-A. & Chern, Y.-T. (1997) In vitro antitumor and antimicrobial activities of N-substituts of maleimide by adamantane and diamantane. Chemotherapy 43, 182-189.
  • 15. Takatori, Y. (1992) N-1-adamantylmaleimide. Jpn. Kokai Tokyo Koho, Japan Pat. 6028961.
  • 16. Sabata, Y., Shichita, M., Sasaki, K., Hashimoto, Y. & Iwasaki, S. (1995) N-Alkylphthalimides: Structural requirement of thalidomidal action on 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor α production by human leukemia HL-60 cells. Chem. Pharm. Bull. 43, 177-179.
  • 17. National Committee for Clinical Laboratory Standards NCCLS Approved Standard Document M7-A. (1985) Villanova, PA, U.S.A.
  • 18. National Committee for Clinical Laboratory Standards 5th edn. Approved Standard NCCLS Document M2-A5. (1993) Villanova, PA, U.S.A.
  • 19. Białecka-Florjańczyk, E. & Orzeszko, A. (1999) Sposób wytwarzania ciekłokrystalicznego bezwodnika 4-cholesteryloksykarbonyloftalowego. Pol. Patent 175659 (in Polish).
  • 20. Białecka-Florjańczyk, E. & Orzeszko, A. (1999) Sposob wytwarzania cieklokrystalicznych estrow cholesterolowych pochodnych bezwodnika 4-cholesteryloksykarbonyloftalowego. Pol. Patent 176084 (in Polish).
  • 21. Kalodera, Z., Popejnak, S., Blazevic, N., Petrak, T. (1997) Chemical composition and antimicrobial activity of Tanacetum parthenium essential oil. Pharmazie 52, 885-886.
  • 22. Kada, T., Hirano, K. & Shirazu, Y. (1980) Screening of environmental chemical mutagens by the rec-assay system with Bacillus subtilis. Chemical Mutagens (de Serres, F.J. & Hollaender, A., eds.) vol. 6, pp. 149-173, Plenum Pub. Co., New York.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.